144 related articles for article (PubMed ID: 22946065)
1. New Zealand Diabetes Cohort Study cardiovascular risk score for people with Type 2 diabetes: validation in the PREDICT cohort.
Robinson T; Elley CR; Wells S; Robinson E; Kenealy T; Pylypchuk R; Bramley D; Arroll B; Crengle S; Riddell T; Ameratunga S; Metcalf P; Drury PL
J Prim Health Care; 2012 Sep; 4(3):181-8. PubMed ID: 22946065
[TBL] [Abstract][Full Text] [Related]
2. Rationale, design and population description of the CREDENCE study: cardiovascular risk equations for diabetes patients from New Zealand and Chinese electronic health records.
Liang J; Pylypchuk R; Tang X; Shen P; Liu X; Chen Y; Tan J; Wu J; Zhang J; Lu P; Lin H; Gao P; Jackson R
Eur J Epidemiol; 2021 Oct; 36(10):1085-1095. PubMed ID: 34420154
[TBL] [Abstract][Full Text] [Related]
3. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
Metcalf PA; Wells S; Scragg RK; Jackson R
N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
[TBL] [Abstract][Full Text] [Related]
4. Performance of Cardiovascular Disease Risk Scores in People Diagnosed With Type 2 Diabetes: External Validation Using Data From the National Scottish Diabetes Register.
Read SH; van Diepen M; Colhoun HM; Halbesma N; Lindsay RS; McKnight JA; McAllister DA; Pearson ER; Petrie JR; Philip S; Sattar N; Woodward M; Wild SH;
Diabetes Care; 2018 Sep; 41(9):2010-2018. PubMed ID: 30002197
[TBL] [Abstract][Full Text] [Related]
5. Derivation and validation of a new cardiovascular risk score for people with type 2 diabetes: the new zealand diabetes cohort study.
Elley CR; Robinson E; Kenealy T; Bramley D; Drury PL
Diabetes Care; 2010 Jun; 33(6):1347-52. PubMed ID: 20299482
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risk prediction in type 2 diabetes before and after widespread screening: a derivation and validation study.
Pylypchuk R; Wells S; Kerr A; Poppe K; Harwood M; Mehta S; Grey C; Wu BP; Selak V; Drury PL; Chan WC; Orr-Walker B; Murphy R; Mann J; Krebs JD; Zhao J; Jackson R
Lancet; 2021 Jun; 397(10291):2264-2274. PubMed ID: 34089656
[TBL] [Abstract][Full Text] [Related]
7. Performance of Framingham cardiovascular risk scores by ethnic groups in New Zealand: PREDICT CVD-10.
Riddell T; Wells S; Jackson R; Lee AW; Crengle S; Bramley D; Ameratunga S; Pylypchuk R; Broad J; Marshall R; Kerr A
N Z Med J; 2010 Feb; 123(1309):50-61. PubMed ID: 20186242
[TBL] [Abstract][Full Text] [Related]
8. Comparative performance of diabetes-specific and general population-based cardiovascular risk assessment models in people with diabetes mellitus.
Echouffo-Tcheugui JB; Kengne AP
Diabetes Metab; 2013 Oct; 39(5):389-96. PubMed ID: 24080092
[TBL] [Abstract][Full Text] [Related]
9. Prediction of Five-Year Cardiovascular Disease Risk in People with Type 2 Diabetes Mellitus: Derivation in Nanjing, China and External Validation in Scotland, UK.
Wan C; Read S; Wu H; Lu S; Zhang X; Wild SH; Liu Y
Glob Heart; 2022; 17(1):46. PubMed ID: 36051323
[TBL] [Abstract][Full Text] [Related]
10. A comparative analysis of the cardiovascular disease risk factor profiles of Pacific peoples and Europeans living in New Zealand assessed in routine primary care: PREDICT CVD-11.
Grey C; Wells S; Riddell T; Kerr A; Gentles D; Pylypchuk R; Marshall R; Ameratunga S; Drury P; Elley CR; Kyle C; Exeter D; Jackson R
N Z Med J; 2010 Feb; 123(1309):62-75. PubMed ID: 20186243
[TBL] [Abstract][Full Text] [Related]
11. High calcium scores in patients with a low Framingham risk of cardiovascular (CVS) disease: implications for more accurate CVS risk assessment in New Zealand.
Ellis CJ; Legget ME; Edwards C; Van Pelt N; Ormiston JA; Christiansen J; Winch H; Osborne M; Gamble G
N Z Med J; 2011 May; 124(1335):13-26. PubMed ID: 21946678
[TBL] [Abstract][Full Text] [Related]
12. Potentially modifiable metabolic factors and the risk of cardiovascular disease hospitalizations in urban African Americans with diabetes.
Cook CB; Hentz JG; Tsui C; Ziemer DC; Naylor DB; Miller WJ
Ethn Dis; 2006; 16(4):852-8. PubMed ID: 17061737
[TBL] [Abstract][Full Text] [Related]
13. Contemporary model for cardiovascular risk prediction in people with type 2 diabetes.
Kengne AP; Patel A; Marre M; Travert F; Lievre M; Zoungas S; Chalmers J; Colagiuri S; Grobbee DE; Hamet P; Heller S; Neal B; Woodward M;
Eur J Cardiovasc Prev Rehabil; 2011 Jun; 18(3):393-8. PubMed ID: 21450612
[TBL] [Abstract][Full Text] [Related]
14. Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial.
Scott R; Donoghoe M; Watts GF; O'Brien R; Pardy C; Taskinen MR; Davis TM; Colman PG; Manning P; Fulcher G; Keech AC;
Cardiovasc Diabetol; 2011 Nov; 10():102. PubMed ID: 22104275
[TBL] [Abstract][Full Text] [Related]
15. All-cause, premature, and cardiovascular death attributable to socioeconomic and ethnic disparities among New Zealanders with type 1 diabetes 1994-2019: a multi-linked population-based cohort study.
Yu D; Cai Y; Osuagwu UL; Pickering K; Baker J; Cutfield R; Orr-Walker BJ; Sundborn G; Wang Z; Zhao Z; Simmons D
BMC Public Health; 2024 Jan; 24(1):298. PubMed ID: 38273238
[TBL] [Abstract][Full Text] [Related]
16. The ADVANCE cardiovascular risk model and current strategies for cardiovascular disease risk evaluation in people with diabetes.
Kengne AP
Cardiovasc J Afr; 2013; 24(9-10):376-81. PubMed ID: 24337215
[TBL] [Abstract][Full Text] [Related]
17. Assessing 10-Year Cardiovascular Disease Risk in Malaysians With Type 2 Diabetes Mellitus: Framingham Cardiovascular Versus United Kingdom Prospective Diabetes Study Equations.
Yew SQ; Chia YC; Theodorakis M
Asia Pac J Public Health; 2019 Oct; 31(7):622-632. PubMed ID: 31535566
[TBL] [Abstract][Full Text] [Related]
18. SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe.
SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration
Eur Heart J; 2023 Jul; 44(28):2544-2556. PubMed ID: 37247330
[TBL] [Abstract][Full Text] [Related]
19. Relationship between estimated glomerular filtration rate and incident cardiovascular disease in an ethnically diverse primary care cohort.
Church E; Poppe K; Harwood M; Mehta S; Grey C; Selak V; Marshall MR; Wells S
N Z Med J; 2019 Mar; 132(1491):11-26. PubMed ID: 30845125
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular risk prediction in a population with the metabolic syndrome: Framingham vs. UKPDS algorithms.
Zomer E; Liew D; Owen A; Magliano DJ; Ademi Z; Reid CM
Eur J Prev Cardiol; 2014 Mar; 21(3):384-90. PubMed ID: 22588087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
